Commvault's Q4 revenue up 13% to $312M

By Chris Stiles • Tuesday, April 28 11:26 • Permanent Link

Commvault ended fiscal 2026 with fourth-quarter revenue of $312 million, up 13% from a year earlier, as subscription revenue climbed 20% to $208 million.

Within subscription revenue, term-based license revenue rose 6% to $114 million, while SaaS revenue jumped 43% to $93 million.

Operating income for the quarter was $17 million, compared with an operating margin of 5.3%. Non-GAAP EBIT was $66 million, with a 21.3% margin. The company generated $132 million in operating cash flow and free cash flow in the quarter.

For the full year, revenue increased 19% to $1.184 billion. Total ARR rose 21% to $1.122 billion, or 18% on a constant-currency basis. Subscription ARR grew 27% to $989 million, or 24% on a constant-currency basis.

Full-year subscription revenue increased 30% to $768 million. Term-based license revenue rose 18% to $435 million, and SaaS revenue climbed 52% to $333 million.

Operating income for the year was $74 million, with a 6.3% margin. Non-GAAP EBIT reached $238 million, with a 20.1% margin. Operating cash flow was $245 million, and free cash flow was $237 million.

Looking ahead, Commvault said first-quarter fiscal 2027 subscription revenue is expected to be between $263 million and $265 million, with non-GAAP EBIT margin around 19%.

For the full fiscal 2027 year, the company is guiding for subscription revenue of $1.115 billion to $1.125 billion, subscription ARR of $1.2 billion to $1.21 billion, total revenue of $1.3 billion to $1.31 billion, non-GAAP EBIT margin of about 20.5%, and free cash flow of $250 million to $260 million. Following these announcements, the company's shares moved 4.18%, and are now trading at a price of $93.92. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.